-

Eurofins Environment Testing Launches PFAS Exposure Self-Collection Blood Test

LUXEMBOURG--(BUSINESS WIRE)--Per- and Polyfluorinated Alkyl Substances (PFAS), such as PFOA and PFOS, known as “forever chemicals”, characteristically resist natural breakdown in the environment and human bodies. The US Centers for Disease Control and Prevention (CDC) reports that exposure to these chemicals may cause adverse health effects.

In a leap forward for PFAS identification through blood testing, Eurofins (Paris:ERF) Environment Testing and its research partners have developed a self-administered sampling kit, PFAS Exposure™. The kit is the first of its kind and uses a simple finger prick. To date, testing for PFAS in blood has relied on serum as an estimation for whole blood and required a blood draw conducted by a healthcare practitioner.

Knowledge of PFAS levels in blood can assist in understanding PFAS exposure from one’s occupation, food, drinking water, indoor air, and consumer products such as cookware and clothing and the environmental effects this has on humans.

Eurofins’ PFAS Exposure™ collection kits are an all-in-one solution that include the essentials for collection and transport, allowing participants to self-collect samples at home or work, and submit them directly to the laboratory.

The PFAS Exposure kit is available through Eurofins’ at-home health testing business, empowerDX. Kits can be purchased online for $399 and are shipped directly to the customers home or business.

Increasing knowledge of PFAS in blood

Eurofins will provide data for 47 PFAS compounds in whole blood, expanding on the CDC National Health and Nutrition Examination Survey (NHANES) study and database where 16 PFAS compounds in serum are reported.

Further information: www.EurofinsPFAS.com

About Eurofins Environment Testing America

The Eurofins Environment Testing network in the US contributes to a clean and safe environment by providing market-leading laboratory testing, monitoring, and consulting services to a wide range of industrial companies, environmental consultants, contractors, retailers and government authorities.

About empowerDX

empowerDX is the online shop for easy at-home health testing. empowerDX specializes in FDA-authorized COVID-19 testing, women’s health, men’s health, sexual health and general wellness testing. empowerDX is positioned to lead the market for cutting edge, self-collected diagnostic and non-diagnostic testing.

To learn more: empowerdxlab.com

About Eurofins – the global leader in bio-analysis

Eurofins is Testing for Life. With 55,000 staff across a network of 900 laboratories in over 50 countries, Eurofins’ companies offer a portfolio of over 200,000 analytical methods.

Eurofins Shares are listed on Euronext Paris Stock Exchange.

Contacts

Brian Williams
ir@eurofins.com

Eurofins

BOURSE:ERF

Release Versions

Contacts

Brian Williams
ir@eurofins.com

More News From Eurofins

The Eurofins Consumer Product Testing Network Completes Significant Laboratory Expansion in Vietnam

HO CHI MINH CITY, Vietnam--(BUSINESS WIRE)--Eurofins Consumer Product Testing Vietnam has completed a major expansion, seeing the laboratory move to a purpose-built 7,000 sq. m laboratory in Ho Chi Minh City. This new facility provides more than two and a half times the floor space of Eurofins Consumer Product Testing Vietnam’s previous site. This investment strengthens the Eurofins Consumer Product Testing network’s capability to deliver world-class testing solutions and supports Vietnam’s rap...

Eurofins: Weekly Report on Share Repurchases From 01st December to 05th December 2025

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins (Paris:ERF): Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 12/01/2025 FR0014000MR3 20 000 58.9527 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 12/02/2025 FR0014000MR3 20 000 59.3808 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 12/0...

Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 30 November 2025

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific SE (Paris:ERF): ANNEXE B Form to be used for the disclosure of the total number of voting rights and capital, in accordance with the law and grand-ducal regulation of 11 January 2008 on transparency requirements for issuers of securities Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedi (including the issuer ID allocated by the CSSF EUROFINS SCIENTIFIC SE – E1013 Identity of t...
Back to Newsroom